# V1 Empirics Check — openai/gpt-5.1-codex-mini (Variant A)

**Model:** openai/gpt-5.1-codex-mini
**Variant:** A
**Date:** 2026-03-14T17:16:10.145470

---

**Idea Fidelity**

The paper follows much of the original manifest: it examines England’s council tax empty homes premium using MHCLG vacancy data and CTB treatment indicators, and it centers the analysis on a difference-in-differences design with event-study diagnostics. However, the implementation departs in two key respects. First, instead of exploiting the rich staggered adoption variation (between the 244 early adopters and 61 non-adopters) highlighted in the manifest, the paper constructs a balanced panel with 269 treated and only five never-treated LAs, treating all adopters as if they switched simultaneously in 2013. This drastically reduces the identifying variation and raises concerns about whether the empirical strategy still matches the original research question. Second, the manifest proposed a dose–response analysis tied to the escalation of the premium (100%, 200%, 300% steps), but the paper does not exploit variation in premium intensity beyond a single binary treatment indicator. These deviations should be justified or corrected.

---

**Summary**

This paper estimates the causal effect of England’s council tax empty homes premium on long-term residential vacancies using a TWFE DiD on a 2004–2025 panel of English local authorities. The author reports a precise null: neither the initial premium nor its escalations had a detectable impact on long-term vacancy levels, both in the main regression and in event-study and Callaway–Sant’Anna estimates. The inference is framed as policy-relevant: the premium fails because structural constraints, not financial incentives, drive most long-term vacancy.

---

**Essential Points**

1. **Identification rests on an undiversified, tiny control group.** The key DiD contrast hinges on only five never-treated authorities, while 269 are treated. This makes the parallel-trends assumption extremely fragile—idiosyncratic shocks in any of the five controls can drive the estimate, and the practical degrees of freedom for clustering are essentially zero. The paper should either expand the control group (e.g., by incorporating late adopters as comparison units or exploiting within-LA treatment timing) or adopt alternative estimators (e.g., synthetic control, matched differences) that do not rely on such a small control set. As currently specified, the inference is not credible.

2. **The paper fails to exploit the staggered adoption/dose variation that motivated the manifest.** Treatment is approximated as a binary “adopted by 2025” indicator with a single switch in 2013, disregarding the manifest’s emphasis on staggered voluntary adoption between 2013 and 2015 and the subsequent premium escalations (100%, 200%, 300%). This not only wastes identification power but also contradicts the policy narrative (intent-to-treat of early adopters versus never adopt). Please re-specify the DiD to use the actual adoption dates (including gradual adoption across years) and, separately, to leverage premium intensity (50%, 100%, 200%, 300%) in a dose–response framework. Otherwise, the paper does not answer the “escalation” question posed in the manifest.

3. **Standard errors and inference are poorly suited to the design.** Clustering by LA with only five never-treated clusters is unreliable, and the paper does not report any wild-bootstrap, randomization inference, or permutation-based robustness to account for the scarce variation. Without such remedies, the confidence intervals reported in Tables 3–5 may be misleading. Please provide inference procedures tailored to few clusters (e.g., Cameron et al. 2008 wild cluster bootstrap, randomization inference over treated-outcome permutations) and show that the null remains precise under those approaches.

If these issues cannot be adequately addressed, the paper’s identification is too weak to support the policy claims, and rejection should be considered.

---

**Suggestions**

- **Reframe the comparison group.** Rather than restricting to five never-treated LAs, consider exploiting the original 61 non-adopters as of 2014, even if some eventually adopted. Construct a staggered DiD that uses adoption timing (e.g., use Goodman-Bacon decomposition or Callaway–Sant’Anna with multiple adoption dates) so that later adopters serve as controls for earlier adopters prior to their own treatment. This will enlarge the control variation, reduce reliance on few clusters, and allow you to trace the effect at different adoption horizons.

- **Exploit premium escalation and heterogeneity in response.** The escalation to 100%, 200%, 300% (and the 2024 100% for 1–2 year empties) provides natural within-LA variation in treatment intensity. Implement specifications that interact the treatment indicator with premium rate (or duration bands) or define treatment as the premium rate paid by each LA and year. This would also allow for a dose–response interpretation that is central to the policy question: does raising the premium drive greater vacancy reductions? If escalation was phased in, you can treat each step as a separate policy shock in an event-study framework.

- **Validate the parallel-trends assumption beyond the event study.** The event study is informative but limited by the small control group. Complement it with placebo tests that use alternative outcomes or fake adoption times across treated LAs only (e.g., treat 2009 as the policy shift or randomly assign “treatment” to subsets of LAs) to see if similar null results arise. Additionally, include balance tests for pre-trends in observable LA characteristics (population growth, housing stock changes, economic indicators) to reassure readers that the treated and comparison groups were on similar trajectories prior to treatment.

- **Address measurement of the outcome and treatment.** Since the premium targets long-term vacancies (six months or more) but the data include all vacants, consider separately analyzing vacancies by duration band if available. If not, use the “LTV share of all vacants” and “per capita LTV” results to motivate why the log outcome should be preferred. Also, clearly document how you construct the treatment variable when LAs changed premium rates over time (e.g., 50% in 2013, 100% in 2019). If the premium varies by duration band within an LA, explain how that heterogeneity is aggregated for the treatment indicator.

- **Improve inference and reporting.** Given the tiny number of controls, the confidence intervals are likely underestimated. Run wild bootstrap standard errors with few clusters and report them alongside the conventional ones. Alternatively, randomize treatment timing across LAs or permute labels to construct empirical distributions for your test statistics. Present the results in the appendix with corresponding p-values so readers can assess the robustness of your exponential null.

- **Explore mechanisms and heterogeneity.** To substantiate the structural-constraint interpretation, provide evidence on whether vacancies in treated LAs cluster in properties with known constraints (probate, derelict housing, etc.). If data permit, show heterogeneous effects by LA property values, vacancy rates, or urban/rural classification. This could demonstrate that the null result is not uniform: perhaps high-demand areas respond more than low-demand ones, but the aggregate effect washes out. Even descriptive statistics showing that most long-term vacancies remain in unresponsive categories would strengthen the narrative.

- **Clarify the policy implications and bounds.** The headline null should be contextualized with the minimal detectable effect and potential power concerns. For example, a tide of pre-existing upward trends in vacancies over the last decade makes even a moderate effect hard to detect; discuss whether the 15% range is informative relative to the magnitude of the vacancy problem (e.g., 303,000 dwellings). Likewise, consider comparing the English experience to that of other jurisdictions (e.g., Vancouver) with more discretionary vacancy stocks to explain when and why vacancy taxes might work.

- **Be transparent about sample selection.** The paper excludes LAs with fewer than 18 years of data; document how many are dropped and whether these exclusions are correlated with treatment status. Provide a table listing the LAs that never adopted the premium throughout the period to reassure readers that they are not systematically different (e.g., only rural districts).

Adopting these suggestions will strengthen the credibility of the identification and make the paper a valuable contribution, even if the main finding remains a precise null.
